BSE filing, NSE: SURAKSHA. Summary written from the filing by ALFA Finder's alert engine.
Suraksha Diagnostic Ltd: key numbers
- Share price
- ₹319.55
- Market cap
- ₹1,664 Cr
- Revenue (annual)
- ₹310.4 Cr
- Net profit (annual)
- ₹32.19 Cr
- P/E (TTM)
- 46.5×Sector 52.3×
- Promoter holding
- 49.10%+0.00% QoQ
- FII holding
- 13.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Suraksha Diagnostic Ltd
All →Suraksha Diagnostic Legal & Regulatory
Suraksha Diagnostic disclosed a one-day delay in shareholding pattern filing, leading to a Rs. 2,360 fine. The Board has noted remedial measures to prevent future recurrence.
Suraksha Diagnostic Management Change
Suraksha Diagnostic has appointed Ms. Shreya Arora as Company Secretary and Compliance Officer, effective October 14, 2026.
Suraksha Diagnostic Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI regulations.
Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Ltd held its 21st AGM on September 22, 2026. Members adopted financial statements, approved a final dividend, and ratified cost auditor remuneration.
Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Limited has issued a notice for its 21st Annual General Meeting scheduled for September 22, 2026, to conduct routine business and dividend declaration.
- Value
- ₹0.01 Cr
Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Limited has issued a notice for its 21st Annual General Meeting to be held on September 22, 2026, to transact key corporate business.
Other other announcement announcements
All →STL Networks Other Announcement
The Monitoring Agency reported Rs. 2 Crore utilization of Preferential Issue proceeds, with no deviations from objects. The report covers the quarter ending September 30, 2026.
HEG Advanced Materials Other Announcement
HEG Advanced Materials Limited has intimated the exchange regarding the change of its Corporate Identification Number (CIN) following an approved scheme of arrangement.
Sanofi India Other Announcement
Sanofi India issued a communication regarding Tax Deduction at Source (TDS) for the interim dividend declared for FY 2026. Shareholders must update details by November 5, 2026.
Visaka Industries Other Announcement
Visaka Industries informed the exchange about sending reminder letters to shareholders regarding the compulsory transfer of unclaimed dividends and equity shares to the IEPF account.
Arvaya Healthcare Other Announcement
Arvaya Healthcare filed its quarterly shareholding pattern under Regulation 31(1)(c). The filing reports routine ownership breakdowns with no transaction.
AYM Syntex Other Announcement
AYM Syntex's board appointed BSR & Co. LLP as statutory auditor for five years, subject to shareholder approval. Routine auditor appointment; no monetary value involved.
- Execution
- Five consecutive years, from the conclusion of the 44th AGM to the conclusion of the 49th AGM